Resultado de búsqueda
12 de dic. de 2022 · In the complete 2023 Standards of Care, see recommendations 14.67–14.73 for guidance on the pharmacologic management of type 2 diabetes in youth and Tables 14.1A and 14.1B for screening and treatment recommendations for type 1 and type 2 diabetes in youth.
This guidance also addresses the new problem of DKA and particularly euglycaemic DKA in those treated with SGLT-2 inhibitors. It also for the first time considers ketosis prone type 2 diabetes and the complex issue of the management of DKA in people with end stage renal failure or on dialysis.
This article summarises the Joint British Diabetes Societies for Inpatient Care guidelines on the management of ketoacidosis; available at https://abcd.care/resource/management-diabetic-ketoacidosis-dka-adults.
27 de feb. de 2022 · These guidelines recommend that management be based on point-of-care testing of those admitted with ketoacidosis. BG is routinely checked using point-of-care testing, but portable ketone meters now also allow point-of-care testing of 3-beta-hydroxybutyrate, the main blood ketone.
10 de jul. de 2023 · Diabetic ketoacidosis (DKA) is characterized by hyperglycemia, acidosis, and ketonemia. It is a life-threatening complication of diabetes and typically seen in patients with type-1 diabetes mellitus, though it may also occur in patients with type-2 diabetes mellitus.
12 de dic. de 2022 · Today, the American Diabetes Association ® (ADA) published Standards of Care in Diabetes—2023 (Standards of Care), comprehensive, evidence-based guidelines for the prevention, diagnosis, and treatment of diabetes.
23 de may. de 2023 · Highlights. Diabetic ketoacidosis is the most frequent hyperglycemic emergency. Diabetic ketoacidosis is the leading cause of death in people with diabetes mellitus. DKA is common in people with type 1 diabetes.
